世界のヒト胚性幹細胞アッセイ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Embryonic Stem Cell Assay Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2944 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ヒト胚性幹細胞アッセイのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生存率/細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス）、用途別市場規模（バイオ医薬品・バイオテクノロジー産業、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒト胚性幹細胞アッセイの市場動向 ・企業の競争状況、市場シェア ・ヒト胚性幹細胞アッセイの種類別市場規模（生存率/細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス） ・ヒト胚性幹細胞アッセイの用途別市場規模（バイオ医薬品・バイオテクノロジー産業、研究所） ・ヒト胚性幹細胞アッセイの北米市場規模2016-2027（アメリカ、カナダ） ・ヒト胚性幹細胞アッセイのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒト胚性幹細胞アッセイのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒト胚性幹細胞アッセイの中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒト胚性幹細胞アッセイの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Thermo Fisher Scientific、Merck、GE Healthcare、Bio-Rad Laboratories、Promega Corporation、Agilent Technologies、Perkinelmer、Miltenyi Biotec、Cell Biolabs、Hemogenix、Stemcell Technologies、Bio-Techne Corporation、Cellular Dynamics International (CDI)） ・結論

Market Analysis and Insights: Global Human Embryonic Stem Cell Assay Market
The global Human Embryonic Stem Cell Assay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Embryonic Stem Cell Assay market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Embryonic Stem Cell Assay market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Embryonic Stem Cell Assay market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Embryonic Stem Cell Assay market.

Global Human Embryonic Stem Cell Assay Scope and Market Size
Human Embryonic Stem Cell Assay market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Embryonic Stem Cell Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Viability/Cytotoxicity
Isolation & Purification
Cell Identification
Proliferation
Differentiation
Function
Apoptosis

Segment by Application
Biopharmaceutical & Biotechnology Companies
Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific
Merck
GE Healthcare
Bio-Rad Laboratories
Promega Corporation
Agilent Technologies
Perkinelmer
Miltenyi Biotec
Cell Biolabs
Bio-Rad Laboratories
Promega Corporation

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Embryonic Stem Cell Assay Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Viability/Cytotoxicity
1.2.3 Isolation & Purification
1.2.4 Cell Identification
1.2.5 Proliferation
1.2.6 Differentiation
1.2.7 Function
1.2.8 Apoptosis
1.3 Market by Application
1.3.1 Global Human Embryonic Stem Cell Assay Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biopharmaceutical & Biotechnology Companies
1.3.3 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Embryonic Stem Cell Assay Market Perspective (2016-2027)
2.2 Human Embryonic Stem Cell Assay Growth Trends by Regions
2.2.1 Human Embryonic Stem Cell Assay Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Embryonic Stem Cell Assay Historic Market Share by Regions (2016-2021)
2.2.3 Human Embryonic Stem Cell Assay Forecasted Market Size by Regions (2022-2027)
2.3 Human Embryonic Stem Cell Assay Industry Dynamic
2.3.1 Human Embryonic Stem Cell Assay Market Trends
2.3.2 Human Embryonic Stem Cell Assay Market Drivers
2.3.3 Human Embryonic Stem Cell Assay Market Challenges
2.3.4 Human Embryonic Stem Cell Assay Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Embryonic Stem Cell Assay Players by Revenue
3.1.1 Global Top Human Embryonic Stem Cell Assay Players by Revenue (2016-2021)
3.1.2 Global Human Embryonic Stem Cell Assay Revenue Market Share by Players (2016-2021)
3.2 Global Human Embryonic Stem Cell Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Embryonic Stem Cell Assay Revenue
3.4 Global Human Embryonic Stem Cell Assay Market Concentration Ratio
3.4.1 Global Human Embryonic Stem Cell Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Embryonic Stem Cell Assay Revenue in 2020
3.5 Human Embryonic Stem Cell Assay Key Players Head office and Area Served
3.6 Key Players Human Embryonic Stem Cell Assay Product Solution and Service
3.7 Date of Enter into Human Embryonic Stem Cell Assay Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Embryonic Stem Cell Assay Breakdown Data by Type
4.1 Global Human Embryonic Stem Cell Assay Historic Market Size by Type (2016-2021)
4.2 Global Human Embryonic Stem Cell Assay Forecasted Market Size by Type (2022-2027)

5 Human Embryonic Stem Cell Assay Breakdown Data by Application
5.1 Global Human Embryonic Stem Cell Assay Historic Market Size by Application (2016-2021)
5.2 Global Human Embryonic Stem Cell Assay Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Embryonic Stem Cell Assay Market Size (2016-2027)
6.2 North America Human Embryonic Stem Cell Assay Market Size by Type
6.2.1 North America Human Embryonic Stem Cell Assay Market Size by Type (2016-2021)
6.2.2 North America Human Embryonic Stem Cell Assay Market Size by Type (2022-2027)
6.2.3 North America Human Embryonic Stem Cell Assay Market Size by Type (2016-2027)
6.3 North America Human Embryonic Stem Cell Assay Market Size by Application
6.3.1 North America Human Embryonic Stem Cell Assay Market Size by Application (2016-2021)
6.3.2 North America Human Embryonic Stem Cell Assay Market Size by Application (2022-2027)
6.3.3 North America Human Embryonic Stem Cell Assay Market Size by Application (2016-2027)
6.4 North America Human Embryonic Stem Cell Assay Market Size by Country
6.4.1 North America Human Embryonic Stem Cell Assay Market Size by Country (2016-2021)
6.4.2 North America Human Embryonic Stem Cell Assay Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Human Embryonic Stem Cell Assay Market Size (2016-2027)
7.2 Europe Human Embryonic Stem Cell Assay Market Size by Type
7.2.1 Europe Human Embryonic Stem Cell Assay Market Size by Type (2016-2021)
7.2.2 Europe Human Embryonic Stem Cell Assay Market Size by Type (2022-2027)
7.2.3 Europe Human Embryonic Stem Cell Assay Market Size by Type (2016-2027)
7.3 Europe Human Embryonic Stem Cell Assay Market Size by Application
7.3.1 Europe Human Embryonic Stem Cell Assay Market Size by Application (2016-2021)
7.3.2 Europe Human Embryonic Stem Cell Assay Market Size by Application (2022-2027)
7.3.3 Europe Human Embryonic Stem Cell Assay Market Size by Application (2016-2027)
7.4 Europe Human Embryonic Stem Cell Assay Market Size by Country
7.4.1 Europe Human Embryonic Stem Cell Assay Market Size by Country (2016-2021)
7.4.2 Europe Human Embryonic Stem Cell Assay Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Embryonic Stem Cell Assay Market Size (2016-2027)
8.2 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Type
8.2.1 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Application
8.3.1 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Region
8.4.1 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Embryonic Stem Cell Assay Market Size (2016-2027)
9.2 Latin America Human Embryonic Stem Cell Assay Market Size by Type
9.2.1 Latin America Human Embryonic Stem Cell Assay Market Size by Type (2016-2021)
9.2.2 Latin America Human Embryonic Stem Cell Assay Market Size by Type (2022-2027)
9.2.3 Latin America Human Embryonic Stem Cell Assay Market Size by Type (2016-2027)
9.3 Latin America Human Embryonic Stem Cell Assay Market Size by Application
9.3.1 Latin America Human Embryonic Stem Cell Assay Market Size by Application (2016-2021)
9.3.2 Latin America Human Embryonic Stem Cell Assay Market Size by Application (2022-2027)
9.3.3 Latin America Human Embryonic Stem Cell Assay Market Size by Application (2016-2027)
9.4 Latin America Human Embryonic Stem Cell Assay Market Size by Country
9.4.1 Latin America Human Embryonic Stem Cell Assay Market Size by Country (2016-2021)
9.4.2 Latin America Human Embryonic Stem Cell Assay Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Embryonic Stem Cell Assay Market Size (2016-2027)
10.2 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Type
10.2.1 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Application
10.3.1 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Country
10.4.1 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Human Embryonic Stem Cell Assay Introduction
11.1.4 Thermo Fisher Scientific Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Human Embryonic Stem Cell Assay Introduction
11.2.4 Merck Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.2.5 Merck Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Details
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Human Embryonic Stem Cell Assay Introduction
11.3.4 GE Healthcare Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.3.5 GE Healthcare Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Human Embryonic Stem Cell Assay Introduction
11.4.4 Bio-Rad Laboratories Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Human Embryonic Stem Cell Assay Introduction
11.5.4 Promega Corporation Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.5.5 Promega Corporation Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Human Embryonic Stem Cell Assay Introduction
11.6.4 Agilent Technologies Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.6.5 Agilent Technologies Recent Development
11.7 Perkinelmer
11.7.1 Perkinelmer Company Details
11.7.2 Perkinelmer Business Overview
11.7.3 Perkinelmer Human Embryonic Stem Cell Assay Introduction
11.7.4 Perkinelmer Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.7.5 Perkinelmer Recent Development
11.8 Miltenyi Biotec
11.8.1 Miltenyi Biotec Company Details
11.8.2 Miltenyi Biotec Business Overview
11.8.3 Miltenyi Biotec Human Embryonic Stem Cell Assay Introduction
11.8.4 Miltenyi Biotec Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.8.5 Miltenyi Biotec Recent Development
11.9 Cell Biolabs
11.9.1 Cell Biolabs Company Details
11.9.2 Cell Biolabs Business Overview
11.9.3 Cell Biolabs Human Embryonic Stem Cell Assay Introduction
11.9.4 Cell Biolabs Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.9.5 Cell Biolabs Recent Development
11.10 Hemogenix
11.10.1 Hemogenix Company Details
11.10.2 Hemogenix Business Overview
11.10.3 Hemogenix Human Embryonic Stem Cell Assay Introduction
11.10.4 Hemogenix Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.10.5 Hemogenix Recent Development
11.11 Stemcell Technologies
11.11.1 Stemcell Technologies Company Details
11.11.2 Stemcell Technologies Business Overview
11.11.3 Stemcell Technologies Human Embryonic Stem Cell Assay Introduction
11.11.4 Stemcell Technologies Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.11.5 Stemcell Technologies Recent Development
11.12 Bio-Techne Corporation
11.12.1 Bio-Techne Corporation Company Details
11.12.2 Bio-Techne Corporation Business Overview
11.12.3 Bio-Techne Corporation Human Embryonic Stem Cell Assay Introduction
11.12.4 Bio-Techne Corporation Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.12.5 Bio-Techne Corporation Recent Development
11.13 Cellular Dynamics International (CDI)
11.13.1 Cellular Dynamics International (CDI) Company Details
11.13.2 Cellular Dynamics International (CDI) Business Overview
11.13.3 Cellular Dynamics International (CDI) Human Embryonic Stem Cell Assay Introduction
11.13.4 Cellular Dynamics International (CDI) Revenue in Human Embryonic Stem Cell Assay Business (2016-2021)
11.13.5 Cellular Dynamics International (CDI) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Embryonic Stem Cell Assay Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Viability/Cytotoxicity
Table 3. Key Players of Isolation & Purification
Table 4. Key Players of Cell Identification
Table 5. Key Players of Proliferation
Table 6. Key Players of Differentiation
Table 7. Key Players of Function
Table 8. Key Players of Apoptosis
Table 9. Global Human Embryonic Stem Cell Assay Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Human Embryonic Stem Cell Assay Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Human Embryonic Stem Cell Assay Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Human Embryonic Stem Cell Assay Market Share by Regions (2016-2021)
Table 13. Global Human Embryonic Stem Cell Assay Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Human Embryonic Stem Cell Assay Market Share by Regions (2022-2027)
Table 15. Human Embryonic Stem Cell Assay Market Trends
Table 16. Human Embryonic Stem Cell Assay Market Drivers
Table 17. Human Embryonic Stem Cell Assay Market Challenges
Table 18. Human Embryonic Stem Cell Assay Market Restraints
Table 19. Global Human Embryonic Stem Cell Assay Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Human Embryonic Stem Cell Assay Market Share by Players (2016-2021)
Table 21. Global Top Human Embryonic Stem Cell Assay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Embryonic Stem Cell Assay as of 2020)
Table 22. Ranking of Global Top Human Embryonic Stem Cell Assay Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Human Embryonic Stem Cell Assay Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Human Embryonic Stem Cell Assay Product Solution and Service
Table 26. Date of Enter into Human Embryonic Stem Cell Assay Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Human Embryonic Stem Cell Assay Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Human Embryonic Stem Cell Assay Revenue Market Share by Type (2016-2021)
Table 30. Global Human Embryonic Stem Cell Assay Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Human Embryonic Stem Cell Assay Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Human Embryonic Stem Cell Assay Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Human Embryonic Stem Cell Assay Revenue Market Share by Application (2016-2021)
Table 34. Global Human Embryonic Stem Cell Assay Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Human Embryonic Stem Cell Assay Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Human Embryonic Stem Cell Assay Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Human Embryonic Stem Cell Assay Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Human Embryonic Stem Cell Assay Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Human Embryonic Stem Cell Assay Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Human Embryonic Stem Cell Assay Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Human Embryonic Stem Cell Assay Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Human Embryonic Stem Cell Assay Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Human Embryonic Stem Cell Assay Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Human Embryonic Stem Cell Assay Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Human Embryonic Stem Cell Assay Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Human Embryonic Stem Cell Assay Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Human Embryonic Stem Cell Assay Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Human Embryonic Stem Cell Assay Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Human Embryonic Stem Cell Assay Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Human Embryonic Stem Cell Assay Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Human Embryonic Stem Cell Assay Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Human Embryonic Stem Cell Assay Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Human Embryonic Stem Cell Assay Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Human Embryonic Stem Cell Assay Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Human Embryonic Stem Cell Assay Market Size by Country (2022-2027) & (US$ Million)
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Human Embryonic Stem Cell Assay Product
Table 69. Thermo Fisher Scientific Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Human Embryonic Stem Cell Assay Product
Table 74. Merck Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. GE Healthcare Company Details
Table 77. GE Healthcare Business Overview
Table 78. GE Healthcare Human Embryonic Stem Cell Assay Product
Table 79. GE Healthcare Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 80. GE Healthcare Recent Development
Table 81. Bio-Rad Laboratories Company Details
Table 82. Bio-Rad Laboratories Business Overview
Table 83. Bio-Rad Laboratories Human Embryonic Stem Cell Assay Product
Table 84. Bio-Rad Laboratories Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 85. Bio-Rad Laboratories Recent Development
Table 86. Promega Corporation Company Details
Table 87. Promega Corporation Business Overview
Table 88. Promega Corporation Human Embryonic Stem Cell Assay Product
Table 89. Promega Corporation Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 90. Promega Corporation Recent Development
Table 91. Agilent Technologies Company Details
Table 92. Agilent Technologies Business Overview
Table 93. Agilent Technologies Human Embryonic Stem Cell Assay Product
Table 94. Agilent Technologies Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 95. Agilent Technologies Recent Development
Table 96. Perkinelmer Company Details
Table 97. Perkinelmer Business Overview
Table 98. Perkinelmer Human Embryonic Stem Cell Assay Product
Table 99. Perkinelmer Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 100. Perkinelmer Recent Development
Table 101. Miltenyi Biotec Company Details
Table 102. Miltenyi Biotec Business Overview
Table 103. Miltenyi Biotec Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 104. Miltenyi Biotec Recent Development
Table 105. Cell Biolabs Company Details
Table 106. Cell Biolabs Business Overview
Table 107. Cell Biolabs Human Embryonic Stem Cell Assay Product
Table 108. Cell Biolabs Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 109. Cell Biolabs Recent Development
Table 110. Hemogenix Company Details
Table 111. Hemogenix Business Overview
Table 112. Hemogenix Human Embryonic Stem Cell Assay Product
Table 113. Hemogenix Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 114. Hemogenix Recent Development
Table 115. Stemcell Technologies Company Details
Table 116. Stemcell Technologies Business Overview
Table 117. Stemcell Technologies Human Embryonic Stem Cell Assay Product
Table 118. Stemcell Technologies Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 119. Stemcell Technologies Recent Development
Table 120. Bio-Techne Corporation Company Details
Table 121. Bio-Techne Corporation Business Overview
Table 122. Bio-Techne Corporation Human Embryonic Stem Cell Assay Product
Table 123. Bio-Techne Corporation Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 124. Bio-Techne Corporation Recent Development
Table 125. Cellular Dynamics International (CDI) Company Details
Table 126. Cellular Dynamics International (CDI) Business Overview
Table 127. Cellular Dynamics International (CDI) Human Embryonic Stem Cell Assay Product
Table 128. Cellular Dynamics International (CDI) Revenue in Human Embryonic Stem Cell Assay Business (2016-2021) & (US$ Million)
Table 129. Cellular Dynamics International (CDI) Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Embryonic Stem Cell Assay Market Share by Type: 2020 VS 2027
Figure 2. Viability/Cytotoxicity Features
Figure 3. Isolation & Purification Features
Figure 4. Cell Identification Features
Figure 5. Proliferation Features
Figure 6. Differentiation Features
Figure 7. Function Features
Figure 8. Apoptosis Features
Figure 9. Global Human Embryonic Stem Cell Assay Market Share by Application: 2020 VS 2027
Figure 10. Biopharmaceutical & Biotechnology Companies Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Human Embryonic Stem Cell Assay Report Years Considered
Figure 13. Global Human Embryonic Stem Cell Assay Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Human Embryonic Stem Cell Assay Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Human Embryonic Stem Cell Assay Market Share by Regions: 2020 VS 2027
Figure 16. Global Human Embryonic Stem Cell Assay Market Share by Regions (2022-2027)
Figure 17. Global Human Embryonic Stem Cell Assay Market Share by Players in 2020
Figure 18. Global Top Human Embryonic Stem Cell Assay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Embryonic Stem Cell Assay as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Human Embryonic Stem Cell Assay Revenue in 2020
Figure 20. Global Human Embryonic Stem Cell Assay Revenue Market Share by Type (2016-2021)
Figure 21. Global Human Embryonic Stem Cell Assay Revenue Market Share by Type (2022-2027)
Figure 22. North America Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Human Embryonic Stem Cell Assay Market Share by Type (2016-2027)
Figure 24. North America Human Embryonic Stem Cell Assay Market Share by Application (2016-2027)
Figure 25. North America Human Embryonic Stem Cell Assay Market Share by Country (2016-2027)
Figure 26. United States Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Human Embryonic Stem Cell Assay Market Share by Type (2016-2027)
Figure 30. Europe Human Embryonic Stem Cell Assay Market Share by Application (2016-2027)
Figure 31. Europe Human Embryonic Stem Cell Assay Market Share by Country (2016-2027)
Figure 32. Germany Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Human Embryonic Stem Cell Assay Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Human Embryonic Stem Cell Assay Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Human Embryonic Stem Cell Assay Market Share by Region (2016-2027)
Figure 42. China Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Human Embryonic Stem Cell Assay Market Share by Type (2016-2027)
Figure 50. Latin America Human Embryonic Stem Cell Assay Market Share by Application (2016-2027)
Figure 51. Latin America Human Embryonic Stem Cell Assay Market Share by Country (2016-2027)
Figure 52. Mexico Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Human Embryonic Stem Cell Assay Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Human Embryonic Stem Cell Assay Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Human Embryonic Stem Cell Assay Market Share by Country (2016-2027)
Figure 58. Turkey Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Human Embryonic Stem Cell Assay Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 63. GE Healthcare Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 64. Bio-Rad Laboratories Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 65. Promega Corporation Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 66. Agilent Technologies Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 67. Perkinelmer Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 68. Miltenyi Biotec Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 69. Cell Biolabs Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 70. Hemogenix Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 71. Stemcell Technologies Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 72. Bio-Techne Corporation Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 73. Cellular Dynamics International (CDI) Revenue Growth Rate in Human Embryonic Stem Cell Assay Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---